We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.66%
2 Healthcare 3.16%
3 Industrials 2.01%
4 Financials 1.98%
5 Consumer Discretionary 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTCH
1226
PUT
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$33.2M 0.01%
519,700
+56,800
+12% +$2.51M
ARRY icon
1227
Array Technologies
ARRY
$803M
$33.1M 0.01%
+768,331
New +$31M
PXD
1228
CALL
DELISTED
Pioneer Natural Resource Co.
PXD
$33.1M 0.01%
290,800
-14,000
-5% -$1.36M
STAY
1229
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
$33.1M 0.01%
2,235,476
+854,703
+62% +$11.1M
ELAN icon
1230
PUT
Elanco Animal Health
ELAN
$13.2B
$33.1M 0.01%
1,078,900
+1,004,200
+1,344% +$30.6M
MRVI icon
1231
Maravai LifeSciences
MRVI
$969M
$32.9M 0.01%
+1,173,529
New +$32.7M
KMB icon
1232
PUT
Kimberly-Clark
KMB
$36.3B
$32.9M 0.01%
244,000
+55,400
+29% +$7.76M
OCUL icon
1233
Ocular Therapeutix
OCUL
$1.79B
$32.9M 0.01%
1,588,874
-33,089
-2% -$491K
APPN icon
1234
CALL
Appian
APPN
$1.98B
$32.9M 0.01%
202,900
+44,600
+28% +$4.99M
UUP icon
1235
Invesco DB US Dollar Index Bullish Fund
UUP
$420M
$32.8M 0.01%
1,354,636
+1,179,024
+671% +$29.3M
QDEL icon
1236
QuidelOrtho
QDEL
$1.14B
$32.8M 0.01%
182,650
+131,792
+259% +$29.3M
BUD icon
1237
AB InBev
BUD
$170B
$32.8M 0.01%
468,827
+461,313
+6,139% +$29.2M
BEKE icon
1238
KE Holdings
BEKE
$18.7B
$32.8M 0.01%
532,516
+285,965
+116% +$19M
WIX icon
1239
PUT
WIX.com
WIX
$2.3B
$32.8M 0.01%
131,100
+12,100
+10% +$3.19M
IBTX
1240
DELISTED
Independent Bank Group, Inc.
IBTX
$32.7M 0.01%
523,488
-277,635
-35% -$15.4M
ITW icon
1241
PUT
Illinois Tool Works
ITW
$82.6B
$32.7M 0.01%
160,400
-58,600
-27% -$12M
TECL icon
1242
PUT
Direxion Daily Technology Bull 3x ETF
TECL
$5.08B
$32.6M 0.01%
803,000
-105,000
-12% -$3.56M
NVO
1243
Novo Nordisk
NVO
$208B
$32.6M 0.01%
934,506
+218,742
+31% +$7.56M
HRB icon
1244
H&R Block
HRB
$5.58B
$32.6M 0.01%
2,053,806
+745,883
+57% +$12.9M
CMI icon
1245
PUT
Cummins
CMI
$87.5B
$32.6M 0.01%
143,400
-93,800
-40% -$21.1M
NTES icon
1246
CALL
NetEase
NTES
$85.3B
$32.6M 0.01%
340,000
-4,000
-1% -$359K
EXAS
1247
PUT
DELISTED
Exact Sciences
EXAS
$32.5M 0.01%
245,400
-29,200
-11% -$3.53M
VLO icon
1248
CALL
Valero Energy
VLO
$90.1B
$32.5M 0.01%
574,500
+12,800
+2% +$628K
CPA icon
1249
Copa Holdings
CPA
$5.76B
$32.5M 0.01%
420,571
+397,939
+1,758% +$26.5M
MLCO icon
1250
PUT
Melco Resorts & Entertainment
MLCO
$2.22B
$32.5M 0.01%
1,750,400
+1,233,100
+238% +$21.4M

Similar funds

Citadel Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.

  • Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.